News

April 13, 2020
Front Page

Exploring Untapped Data in COVID-19

Dr. Nicholas Tatonetti, a member of the Herbert Irving Comprehensive Cancer Center and associate professor of biomedical informatics at Columbia's Vagelos College of Physicians and Surgeons, has teamed up with colleagues in bioinformatics, urban policy and affairs, and infectious disease on a new data-collection app and website for tracking the impact of the COVID-19 pandemic in New York City.
Read More >
April 13, 2020
Blog & Newsletter

Shared Resource Spotlight: Molecular Pathology

The Molecular Pathology Shared Resource (MPSR) is a comprehensive service for researchers and scientists conducting cutting-edge experimental, basic science, and translational research at the Herbert Irving Comprehensive Cancer Center. Led by founding director Hanina Hibshoosh, MD, MPSR facilitates tissue-based cancer research offering state-of-the-art services in tissue banking, tissue characterization and analysis, and project management and consultation.
Read More >
April 13, 2020
Blog & Newsletter

Managing Stress During COVID-19

Ian J. Sadler, PhD, shares some thoughts and strategies for managing stress during the COVID-19 pandemic.
Read More >
April 7, 2020
Front Page

Cracking Down on COVID-19

In a span of just a couple of weeks, a team of volunteers—primarily students, postdocs, and staff scientists—have come together to assist with the surging COVID-19 response across Columbia University Irving Medical Center. Labeled Columbia University Researchers Against COVID-19, or CRAC for short, the effort has garnered nearly 400 volunteers and the team has already activated numerous projects across Columbia to combat COVID-19.
Read More >
A new study, led by HICCC member Dr. Kenneth Olive, suggests a compound for a rare kidney stone disease could lead to new therapies for pancreatic cancer. The study was published Apr. 2 in the journal, Science.
Read More >
Researchers from the Herbert Irving Comprehensive Cancer Center are swiftly transforming their discoveries and innovation in cancer to address COVID-19.
Read More >
Ben Izar, MD, PhD, who recently joined the Herbert Irving Comprehensive Cancer Center and the Vagelos College of Physicians and Surgeons, has been named a 2020 Louis V. Gerstner, Jr. Scholar. The award honors physicians whose research has the promise of bringing innovative treatments to patients. Find out about Dr. Izar and his work in melanoma and cancer immunotherapies.
Read More >

Pages